作为瘤免疫微环境的关键参与者,杆细胞驱动胃瘤中的铁亡
1Department of Genetics and Bioengineering, Istanbul Bilgi University, Eyupsultan, Turkey.
Omics : a journal of integrative biology
|August 20, 2025
概括
在胃癌中,细胞促进铁亡,一种依赖铁的细胞死亡. 这项研究揭示了
科学领域:
- 癌症学
- 免疫学
- 细胞死亡研究
背景情况:
- 铁死是一种依赖于铁的氧化细胞死亡,在癌症和免疫反应中至关重要.
- 胃癌中的铁和特定免疫细胞之间的确切相互作用尚不清楚.
- 了解这些联系对于开发新的癌症诊断和治疗方法至关重要.
研究的目的:
- 在胃癌中研究与铁死相关的免疫细胞的动态.
- 阐明质细胞在瘤微环境 (TME) 中的作用.
- 确定胃癌的潜在治疗点.
主要方法:
- 胃癌数据集的综合转录组分析 (TCGA-STAD,GSE66229).
- 使用单样基因组丰富分析对GC免疫亚型进行聚类.
- 对共同培养的细胞和患者组织进行大量和单细胞RNA测序 (scRNA-seq) 分析.
主要成果:
- 免疫炎症亚型 (HIS) 呈现出最大的铁缩,与巨细胞和中性粒细胞相关.
- 乳腺细胞对TME中的纤维细胞的铁缩产生了积极的影响.
- 在GC中,scRNA- seq证实了与瘤相关纤维细胞的铁死相关的强化性相互作用.
结论:
- 巨细胞可能通过对膜信号传递诱导TME中的铁亡,可能涉及附素和环素A.
- 这项研究揭示了巨细胞在瘤微环境中的新功能.
- 这些发现为胃癌诊断和治疗提供了新的途径.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.5K
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.0K
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
